Microbiologically documented infections in patients undergoing high-dose melphalan and autologous stem cell transplantation for the treatment of light chain amyloidosis. [electronic resource]
Producer: 20131024Description: 187-94 p. digitalISSN:- 1399-3062
- Aged
- Aged, 80 and over
- Amyloidosis -- therapy
- Bacterial Infections -- diagnosis
- Combined Modality Therapy
- Cross Infection -- etiology
- Dose-Response Relationship, Drug
- Female
- Humans
- Immunoglobulin Light Chains
- Male
- Melphalan -- administration & dosage
- Middle Aged
- Mycoses -- diagnosis
- Myeloablative Agonists -- administration & dosage
- Postoperative Complications
- Risk Factors
- Stem Cell Transplantation -- adverse effects
- Transplantation, Autologous
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.